Inventor
MACLEAN DAVID B
US23 patents
⚠️ This page may combine multiple inventors who share the name “MACLEAN DAVID B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
17 patentsUS6107331AAug 22, 2000
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER50 citations96
US5889042AMar 30, 1999
Method of treating diseases and conditions with estrogen agonists and antagonists
PFIZER54 citations96
US6911456B2Jun 28, 2005
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER12 citations92
US6613796B2Sep 2, 2003
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER13 citations92
US6355670B1Mar 12, 2002
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER17 citations92
US6017964AJan 25, 2000
Method of increasing testosterone
PFIZER26 citations92
US6403611B2Jun 11, 2002
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER13 citations82
US6274618B1Aug 14, 2001
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER14 citations82
US5861438AJan 19, 1999
Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists
PFIZER14 citations74
US5773477AJun 30, 1998
Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists
PFIZER13 citations74
US5719191AFeb 17, 1998
1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's disease
PFIZER8 citations74
US6100301AAug 8, 2000
Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists
PFIZER3 citations63
US5726207AMar 10, 1998
Protection of ischemic myocardium against reperfusion damage
PFIZER5 citations63
US5719190AFeb 17, 1998
Inhibition of myeloperoxidase activity
PFIZER5 citations63
US6057309AMay 2, 2000
Combination therapy to prevent bone loss-progesterone and estrogen agonists
PFIZER0 citations52
US5985932ANov 16, 1999
Inhibition of autoimmune diseases
PFIZER0 citations52
US5733937AMar 31, 1998
Methods for alleviating symptoms of premenstrual syndrome and late luteal phase dysphoric disorder
PFIZER1 citations52